Oxcarbazepine
- Product NDC
- 71428-007
- 11-digit product format
- 714280007
- Labeler code
- 71428
- Product ID
- 71428-007_ee9d7ea0-c2ea-52cb-e053-2995a90a5ff7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- oxcarbazepine
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Glasshouse Pharmaceuticals Limited Canada
- Application
- ANDA212428
- Marketing category
- ANDA
- Marketing start
- 2021-09-21
- Marketing end
- 0000-00-00
- Substance
- OXCARBAZEPINE
- Active strength
- 300 mg/5mL
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71428-007-25 | 71428000725 | 1 BOTTLE in 1 CARTON (71428-007-25) > 250 mL in 1 BOTTLE | 1 bottle | 2021-09-21 | 0000-00-00 | No | No | Current |